Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology employs molecular simulations to explore a wide array of proteins, capturing their dynamic states both individually and within complexes. Through ensemble virtual screening, we address conformational mobility, uncovering binding sites within functional regions and remote allosteric locations. This thorough exploration ensures no potential mechanism of action is overlooked, aiming to discover novel therapeutic targets and lead compounds across an extensive spectrum of biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
Q8N987
UPID:
NECA1_HUMAN
Alternative names:
Neuronal calcium-binding protein 1
Alternative UPACC:
Q8N987; Q6NUS7; Q96AZ7; Q9HBW8
Background:
N-terminal EF-hand calcium-binding protein 1, also known as Neuronal calcium-binding protein 1, plays a crucial role in calcium signaling. This protein, identified by the accession number Q8N987, is pivotal in regulating various cellular processes through its ability to bind calcium ions. Its unique structure, characterized by the EF-hand motif, allows for a high degree of specificity and affinity towards calcium, making it an essential player in neuronal activity.
Therapeutic significance:
Understanding the role of N-terminal EF-hand calcium-binding protein 1 could open doors to potential therapeutic strategies. Its involvement in calcium signaling pathways offers a promising avenue for the development of novel treatments targeting neurological disorders.